Exploring the Potential: GLP-1 Receptor Agonists for Advanced Therapies in End-Stage Heart Failure

被引:0
|
作者
Azmeen, A. [1 ]
Basheer, A. [1 ]
Brink, H. [2 ]
Zolty, R. [1 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Nebraska Med Ctr, Omaha, NE USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
448
引用
收藏
页码:S224 / S224
页数:1
相关论文
共 50 条
  • [31] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [32] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [33] GLP-1 receptor agonists in clinical practice
    Perez, Antonio
    MEDICINA CLINICA, 2024, 163 (05): : 242 - 244
  • [34] GI Effects of GLP-1 Receptor Agonists
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 191 - 192
  • [35] Novel GLP-1 receptor agonists for diabetes
    Garber, Alan J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 45 - 57
  • [36] The promise and hope of GLP-1 receptor agonists
    Sumithran, Priya
    Ard, Jamy
    LANCET DIABETES & ENDOCRINOLOGY, 2025, 13 (01): : 2 - 3
  • [37] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [38] Variable Responses to GLP-1 Receptor Agonists
    Kunwar, Sandeep
    Samson, Kaeli
    Davis, Clifton
    Shivaswamy, Vijay
    Desouza, Cyrus
    DIABETES, 2022, 71
  • [39] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [40] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20